AUROPHARMAPharmaceuticals
Aurobindo Pharma Ltd — Quarterly Results & Earnings
₹1304.40
+0.49%
Profit Growth YoY3.80%Latest quarter
Sales Growth YoY6.28%Latest quarter
Sales CAGR 5Y6.55%5 year compound
Profit CAGR 5Y3.87%5 year compound
📋
Quarterly Performance
YoY Profit Growth+3.80%
📈 Moderate growth
YoY Sales Growth+6.28%
📈 Moderate growth
OPM 5Y Average
19.25%Operating profit margin
EPS Growth 5Y
4.05%Interest Coverage
12.77Higher = safer debt servicing
ROE
11.08%ROCE
14.18%💡
Growth Analysis
Aurobindo Pharma Ltd reported YoY profit growth of 3.80% and revenue growth of 6.28% in the latest quarter. Positive profit growth shows business expansion. Over 5 years, sales compounded at 6.55% and profits at 3.87% annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.
More on Aurobindo Pharma Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.